Kiniksa Pharmaceuticals' Q3 Net Income, Revenue Rise; Shares Up Pre-Bell

08:10 AM EDT, 10/27/2026 (MT Newswires) -- Kiniksa Pharmaceuticals International (KNSA) shares were up 12% pre-bell after it reported Q3 earnings Tuesday of $0.56 per diluted share, compared with $0.23 a year earlier. Four analysts surveyed by FactSet expected $0.35. Revenue for the quarter ended Sept. 30 was $286 million, compared with $180.9 million a year earlier. Analysts surveyed by FactSet expected $260.7 million.